Article Text

Download PDFPDF
Cochrane corner: text messaging to improve adherence to drugs for secondary prevention of cardiovascular disease

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors This editorial was written by AJA, J-PC, NM and PP and based on the systematic review planned, conducted and reported by them and other authors.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests PP has received a grant from the Medical Research Council (MRC) to develop a pilot trial to evaluate efficacy of text message to improve adherence to cardiovascular medications in secondary prevention. J-PC is the primary supervisor of a PhD student funded through an Industrial Case Engineering and Physical Sciences Research Council (EPSRC) studentship, where the industrial partner is Glaxo Smith Kline (GSK) .

  • Patient consent Not required.

  • Provenance and peer review Commissioned; externally peer reviewed.